Srl

Agilus Diagnostics Ltd has taken the initial step in going public by filing preliminary papers with the capital markets regulator, the Securities and Exchange Board of India (Sebi), to raise funds through an initial public offering (IPO).

Microsoft, SRL come together to expand AI network to pathology

With this addition, Microsoft's AI Network for Healthcare has now expanded to include pathology along with eyecare and cardiology, it added.

CCI clears Fortis group's 'internal reorganisation'

Under the deal, Fortis will be carrying out the rejig that involves three entities -- Fortis Healthcare Ltd (FHL), Fortis Malar Hospitals Ltd (FMHL) and SRL Ltd (SRL).

SRL likely to be valued 25 times FY18 operating profit:Macquarie

Singhal sees significant opportunity for diagnositics players such as Dr Lal Path Labs, Thyrocare and SRL. Organised players are already gaining market share and companies which maintain quality standards will definitely do well, he says.

Buy Fortis Healthcare on diagnostic biz demerger, says Nomura

The firm believes that the separation of the hospitals and diagnostics business into separate entities is going to be positive.

Fortis Healthcare Q1 net profit at Rs 25.26 cr

Fortis Healthcare today reported a consolidate net profit of Rs 25.26 crore for the first quarter ended June 30, 2016.

In talks with investors for SRL: Fortis Healthcare

Fortis Healthcare today said it is in talks with a number of investors to facilitate an exit by the existing PE investors from the company's diagnostic arm SRL.

Samruddhi Realty IPO: Spending Rs 60 Lk to raise Rs 2.6 cr!

Considering Samruddhi Realty's age (10 years) and promoters' experience (19 years), a premium of Rs 2 may be too small. But, making a tiny IPO and spending nearly a fourth on issue-related expenses questions the motive, says VS Fernando.

Buy Speciality Restaurants; target Rs 228: Anand Rathi

Anand Rathi Retail Research is bullish on Speciality Restaurants (SRL) and has recommended buy rating on the stock with a target price of Rs 228 in its research report dated December 19, 2012.

Fortis to use proceeds from Dental Corp sale to pare debt

Fortis Healthcare will use the entire proceeds from its 64 percent stake in Dental Corporation Holdings Ltd (DC), Australia to pare debt, says Vishal Bali, Global CEO. The company's stake in DC will be sold to Bupa for 270 million Australian dollar (around Rs 1,554.36 crore) by March 2013.

Apply for Speciality Rest IPO for long term: AB Money

Aditya Birla Money has come out with its report on Speciality Restaurants (SRL)'s IPO issue. The research firm recommends only long term investors to subscribe to the issue.

Avigo PE Investments picks up 9.27% in SRL as pre IPO deal

Avigo Capital Partners, an Indian private equity fund manager with a focus on private equity investments in the SME sector in India, today announced the signing of share subscription agreement with Super Religare Laboratories.